Invesco’s iShares Biotechnology ETF IBB Stock Holding History

Invesco’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-8,985	Closed	-$680K	–	4154
2013 Q4	$680K	Sell	8,985 -570	-6%	-$40.4K	﹤0.01%	3313
2013 Q3	$667K	Buy	9,555 +285	+3%	+$18.7K	﹤0.01%	3252
2013 Q2	$538K	Buy	+9,270	New	+$536K	﹤0.01%	3244

Other funds holding IBB

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Invesco's IBB Position: Q1 2014 in Review

Invesco sold out of iShares Biotechnology ETF (IBB) in Q1 2014, closing a stake of 8,985 shares — an estimated $680K sold.

Invesco first reported a position in IBB in Q2 2013 and held it in 3 quarters. The position peaked at $680K in Q4 2013. 289 funds tracked by Wall St. Rank hold IBB as of Q1 2014.

Invesco reported no remaining iShares Biotechnology ETF position as of Q1 2014 after selling out during the quarter.
Invesco sold 8,985 iShares Biotechnology ETF shares in Q1 2014, an estimated $680K.
Invesco first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 3 quarters.
Invesco's iShares Biotechnology ETF position peaked at $680K in Q4 2013.
289 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2014.

Based on Invesco's 13F filing for Q1 2014, filed 15 May 2014.